摘要
目的比较机器人辅助经腹腹腔镜肾部分切除术(RALPN)与后腹腔镜下肾部分切除术(RLPN)治疗早期肾癌的疗效和安全性,探讨RALPN的临床应用价值。方法选取2010年5月至2013年10月收治的70例肾癌患者,根据术式的不同分为RALPN组(n=36)和RLPN组(n=34)。比较两组手术时间、肾动脉阻断时间、术中出血量、术中输血率、术后住院时间及术后并发症发生情况。结果除RLPN组有2例术中转开放手术,两组均成功完成手术。RALPN组和RLPN组的手术时间、肾动脉阻断时间、术中出血量、术后住院时间分别为(90.5±12.6)min和(110.7±20.3)min、(15.2±5.8)min和(24.6±7.2)min、(50.2±9.5)ml和(130.2±22.4)ml、(6.1±1.7)d和(7.8±2.2)d,两组比较差异均有统计学意义(P<0.05)。RALPN组和RLPN组的术中输血率分别为0和11.8%。RALPN组术后出现1例肾周血肿,RLPN组出现1例尿漏和2例继发性出血。两组在随访期间均为无瘤生存。结论 RALPN是治疗肾癌安全、有效的微创术式。
Objective To compare the efficacy and safety between the robotic-assisted transperitoneal laparoscopic partial ne-phrectomy( RALPN) and retroperitoneal laparoscopic partial nephrectomy( RLPN) in treating early renal carcinoma. Methods Retro-spective review of 70 renal carcinoma patients from May 2010 to October 2013 was conducted. Thirty-six patients were performed with RALPN( RALPN group) , and 34 patients underwent RLPN( RLPN group) . The operation time, renal artery clamping time, intraoper-ative blood transfusion, blood loss, postoperative hospital stay and post-operative complications between the two groups were observed and compared. Results Both the two groups were performed successfully, and 2 cases intraoperatively convered to open surgery in RLPN group. The operation time, renal artery clamping time, blood loss and postoperative hospital stay of RALPN and RLPN group were(90. 5±12. 6)min and(110. 7±20. 3)min,(15. 2±5. 8)min and(24. 6±7. 2)min,(50. 2±9. 5)ml and(130. 2±22. 4)ml, (6. 1± 1. 7)d and (7. 8±2. 2)d. There were significant differences between the two groups (P〈0. 05). The intraoperative blood transfusion between RALPN group and RLPN group were 0 and 11. 8%. In RALPN group, perirenal hematoma post-operation was found in one case, and in RLPN group, one case of urine leakage and 2 cases of secondary hemorrhage were found post-operation. All patients were of turmor-free survival. Conclusion RALPN is a quite effective, safe and minimally invasive surgical management for renal carcinoma with less post-operative complications.
出处
《临床肿瘤学杂志》
CAS
2014年第10期906-909,共4页
Chinese Clinical Oncology
基金
国家自然科学基金资助项目(81271592)